Pharmaceuticals Test-Drive the Cloud

Add Your Comments

cloudsWhich industries are seeing strong enterprise adoption of cloud computing? The pharmaceutical industry, for one. Chemical and Engineering News highlights how several drug makers are test-driving the cloud.  Among them is Eli Lilly & Co., which has used Amazon’s EC2 platform to rapidly deploy compute capacity. 

“We were recently able to launch a 64-machine cluster computer working on bioinformatics sequence information, complete the work, and shut it down in 20 minutes,” Lilly’s Dave Powers told the magazine. “It cost $6.40. To do that internally—to go from nothing to getting a 64-machine cluster installed and qualified—is a 12-week process.”

Security remains a concern for some types of applications. Some pharmaceuticals are discussing the viability of the cloud for managing clinical trial data. An excerpt: 

Karen Riley, a spokeswoman for the Food & Drug Administration, says cloud computing is clearly new territory. “If cloud services become the archive for clinical trial data, our concern would be to safeguard the system for write protection in order to prevent tampering,” she says. Auditing companies such as Google would not be practical, she says, and the responsibility for data security would likely remain with the trial sponsors. Riley notes that FDA already trusts secure external servers for e-mail communication of clinical trial data.

About the Author

Rich Miller is the founder and editor at large of Data Center Knowledge, and has been reporting on the data center sector since 2000. He has tracked the growing impact of high-density computing on the power and cooling of data centers, and the resulting push for improved energy efficiency in these facilities.

Add Your Comments

  • (will not be published)